Video Summary - Alzheimer's disease - plaques, tangles, causes, symptoms & pathology

Scientific concepts, discoveries, and nature/biology phenomena

Dementia is not a single disease; it is a syndrome.
It describes symptoms such as:
- Poor memory
- Difficulty learning new information
It is typically caused by brain cell damage from various diseases.

Most common cause of dementia
A neurodegenerative disease characterized by loss/degeneration of neurons, especially in the cortex
The full pathogenesis is not completely understood, but progression is strongly associated with:
- Amyloid plaques (extracellular)
- Neurofibrillary tangles (intracellular)

APP is a protein located in the neuron membrane, with parts both inside and outside the cell.
Under normal conditions, APP is:
- Cleaved by alpha secretase + gamma secretase
- Producing a soluble product that is removed (considered normal/good)
APP becomes pathological when cleaved differently:
- Beta secretase + gamma secretase cleave APP into amyloid beta fragments
- Amyloid beta forms monomers described as sticky
- These monomers aggregate outside neurons, forming beta-amyloid plaques

Plaques can interfere with neuron-to-neuron signaling, impairing functions such as memory
Plaques may trigger an immune response and inflammation, which may damage nearby neurons
Amyloid can also deposit around brain blood vessels:
- Amyloid angiopathy
- Leads to weakened vessel walls
- Increases risk of hemorrhage (rupture and bleeding)

Neurons rely on a cytoskeleton partly made of microtubules (track-like structures for transporting nutrients and molecules)
Tau helps stabilize microtubules (compared to railway ties)
Suggested mechanism (not fully understood):
1. Beta-amyloid plaque buildup activates intracellular pathways, including kinase activation
2. Kinase transfers phosphate groups to tau, making it abnormal
3. Abnormal tau:
  - Stops supporting microtubules
  - Clumps/clusters with other tau proteins, forming neurofibrillary tangles (intracellular)
Neurons with tangles and impaired microtubules signal less effectively and may undergo apoptosis (programmed cell death)

Alzheimer disease is commonly divided into:

Majority of cases (late-onset)
Caused by a combination of genetic and environmental risk factors
Risk increases with age (e.g., ~1% at age 60–65; ~50% over 85)
APOE-e4 allele increases risk:
- Inheriting one e4 allele increases risk
- Inheriting two e4 alleles increases risk further
APOE helps break down beta-amyloid, but e4 is less effective than e2, leading to more amyloid plaque formation

5–10% of cases (early onset)
Due to dominant gene mutations that speed progression
Key genes:
- PSEN-1 (chromosome 14) and PSEN-2 (chromosome 1)
  - Encode presenilin-1/2, subunits of gamma-secretase
  - Mutations can alter where gamma-secretase cleaves APP, producing beta-amyloid variants that clump more easily into plaques
Trisomy 21 (Down syndrome):
- Extra copy of chromosome 21
- APP gene is on chromosome 21 → increased APP expression → presumed increased amyloid plaque
- Often progresses earlier (described as around age 40)

Symptoms worsen as plaques and tangles build and neuronal damage accumulates
Early:
- Often subtle/not detectable
- Short-term memory loss (e.g., forgetting breakfast)
Middle:
- Loss of motor skills (e.g., needing help with eating)
- Language difficulties (communication impairment)
Late:
- Long-term memory loss (e.g., forgetting spouse/name; forgetting being married)
- Disorientation, which can lead to wandering
- Bedridden
- Common cause of death: infection, specifically pneumonia

Definitive diagnosis requires brain biopsy after autopsy
Clinicians diagnose by excluding other causes of dementia
There is no cure currently
Medications exist, but described benefits are small, and none are said to clearly halt progression

No specific researchers or named external sources are mentioned in the provided subtitles.